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It has been postulated that dual infections of humans with human immunodeficiency virus (HIV) and human T-cell leukemia/
lymphotropic virus (HTLV) may potentiate disease progression. Counterparts of both of these pathogenic human retroviruses
have been identified in various simian species indigenous to Asia and Africa, including sooty mangabey monkeys (Cercocebus
atys). Using peripheral blood mononuclear cells (PBMC) from a mangabey naturally infected with both SIV and STLV-I, T-
cell lines were established and maintained continuously for more than 3 years; these cell lines harbored only a newly
identified mangabey STLV-I(sm) or both STLV-I(sm) and the acutely lethal variant SIVsmmPBj14. The dually infected cell
line (FEd-P14) was established by de novo infection of mangabey PBMC with SIVsmmPBj14. This cell line was characterized
by multiple assays which showed that structural proteins encoded by both viruses were produced in large quantities, but
that the predominant viral glycoprotein on the cell surface was the STLV-I(sm) Env. Unusual interactions of the two retroviral
glycoproteins were suggested by the formation of syncytia between Raji and the FEd-P14 cells, but not between Raji and
simian cells infected with only one retrovirus or human cells infected with HTLV-I. The STLV-I(sm) strain obtained from the
sooty mangabey was transmitted to normal macaque and mangabey PBMC and was shown to be unique by sequencing of
the entire env gene. STLV-I(sm) from this African species was more closely related to ‘‘cosmopolitan’’ HTLV-I strains than
to the prototypic STLV-I from an Asian pig-tailed macaque. In vitro and in vivo studies of STLV-I(sm) and SIVsmm, both isolated
from a naturally infected mangabey monkey, may provide insight into disease induction and manifestations associated with
coinfection by their human counterparts. q 1997 Academic Press
INTRODUCTION ever, found no statistical difference between HIV burdens
in persons infected only with HIV-I and those in persons
Two groups of pathogenic human retroviruses have
coinfected with HIV-I and HTLV-I (Harrison et al., 1997).
been identified: the first group is composed of the geneti-
Because of the continuing spread of HIV infection
cally diverse human immunodeficiency viruses (HIV) throughout the world, including spread into areas and
types 1 and 2, members of the lentivirus subfamily; the subpopulations where the HTLVs are endemic or highly
second group is composed of the complex C-type retrovi- prevalent (such as in the Caribbean and among intrave-
ruses, human T-cell leukemia/lymphoma viruses (HTLV) nous drug abusers), there is increasing likelihood that
types I and II. (HTLV-I and -II are often referred to as more people will acquire dual infections (Cortes et al.,
human T-cell lymphotropic viruses.) In persons dually 1989; Lee et al., 1989; Anderson et al., 1991; Des Jarlais
infected with retroviruses from both of these families, et al., 1992; Briggs et al., 1995). Thus, it is important to
there is suggestive evidence for potentiation of HIV-re- define the potential impact on disease of interactions
lated disease progression and unusual clinical presenta- between these two virus families. Although interactions
tions (Bartholomew et al., 1987; Hattori et al., 1989; between HIV and HTLV can be studied in tissue culture,
Naucler et al., 1992; Harrington et al., 1995). The possibil- it is not possible to manipulate such infections in humans
ity for disease enhancement is supported by in vitro data experimentally. Thus, an animal model would provide a
which show that in T-cell lines harboring HTLV-I or HTLV- way to define disease potential in dually infected individ-
II, HIV replication often occurs at a faster rate, and uals, to test new strategies for therapeutic intervention,
greater numbers of progeny viruses are produced; the and to develop vaccines.
reciprocal effect on HTLV production may also be true Counterparts of both HIV and HTLV have been isolated
(Harada et al., 1985; Montefiori and Mitchell, 1987; Zack from multiple species of nonhuman primates. While only
et al., 1988; De Rossi et al., 1991). A recent study, how- African species of monkeys appear to be the natural
hosts for the simian lentiviruses (SIVs) (for review, see
Gardner et al., 1994), both African and Asian species1 To whom correspondence and reprint requests should be ad-
are infected in the wild by the simian T-cell leukemia/dressed at UAB Station, BBRB 511, Birmingham, AL 35294. Fax: (205)
975-6788. lymphoma type I (STLV-I) retroviruses (for review, see
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Fultz, 1994). Thus, only African nonhuman primates, such one strain, isolated from peripheral blood mononuclear
cells (PBMC) of mangabey FEd and designatedas sooty mangabeys (Cercocebus atys) and green mon-
keys (Cercopithecus aethiops), have the potential to be- SIVsmm9, was selected as a prototype for pathogenicity
studies in macaques (Fultz et al., 1986). Subsequently, acome infected naturally with members of both retrovirus
families. In the few instances where SIV and STLV-I were unique SIV variant was isolated from a pig-tailed ma-
caque (PBj) that died of an AIDS-like disease 14 monthsindigenous to large groups of these animals, infection
with one retrovirus family appeared to increase the risk after infection with SIVsmm9 (Fultz et al., 1989). This vari-
ant, SIVsmmPBj14 (SIV-PBj14), is distinct from all otherfor coinfection (Durand et al., 1995). However, coinfection
did not seem to increase the incidence of immunodefi- simian lentiviruses for several reasons: (i) it induces an
acute disease syndrome in both pig-tailed macaques (M.ciency or neoplastic disease (Fultz et al., 1990; Georges-
Courbat et al., 1996). This observation might be explained nemestrina) and SIV-seronegative mangabeys that leads
to death within 6 to 10 days (Fultz et al., 1989); (ii) itpartially by the fact that SIV does not induce disease in
its natural hosts. It is only after experimental inoculation replicates efficiently in quiescent macaque lymphocytes
(Fultz, 1991); and (iii) it activates and induces proliferationof various species of Asian macaques (Macaca species)
with SIV isolates belonging to the HIV-2/SIVsmm/SIVmac of quiescent macaque lymphocytes (Fultz, 1991).
This report describes a mangabey T-cell line that issubgroup of primate lentiviruses that AIDS-like immuno-
deficiency disease usually ensues. Among the first iso- coinfected with SIV-PBj14 and a new C-type retrovirus
closely related to HTLV-I, which we have designatedlates of SIV were those obtained from naturally infected
sooty mangabeys in a semi-free-ranging, domestic STLV-I(sm). STLV-I(sm) was initially identified in a contin-
uous T-cell line established from PBMC from a naturallybreeding colony that was started in the 1960s with feral
mangabeys (Fultz et al., 1986). Retrospective analysis of infected sooty mangabey. Continuous simian T-cell lines
that harbor the mangabey STLV-I(sm) or both SIV-PBj14serum samples from these animals indicated that the
viruses were present as a result of natural infections in and STLV-I(sm) will be valuable reagents for evaluating
intracellular interactions of these two retrovirus families.some of the original founder animals. Later serologic
studies showed that mangabeys in this colony were also Furthermore, extension of the present studies with the
simian counterparts of the human pathogens to in vivonaturally infected with a virus closely related to HTLV-I
(Fultz et al., 1990). infections of macaques might provide insight into dis-
eases associated with dual infections of HIV and HTLVA strong causal relationship has been established be-
tween lymphoproliferative diseases, such as malignant in humans.
lymphomas and T-cell leukemias, and STLV-I infection in
macaques, baboons, African green monkeys, and sooty MATERIALS AND METHODS
mangabeys (Homma et al., 1984; Sakakibara et al., 1986;
Cell lines and viruses
Tsujimoto et al., 1987; McCarthy et al., 1990; McClure et
al., 1992; Traina-Dorge et al., 1992). However, in contrast In addition to the newly established cell lines (FEd-
P14, FEd-M9, 11F-FEd-M9, and FAi-FEd-P14) and the vi-to leukemias/lymphomas that result from HTLV-I infec-
tions in humans, STLV-I-induced disease in nonhuman ruses they harbor, which are described under Results,
the following human cell lines were used: Molt4 clone 8primates can be associated with cells expressing either
CD4 or CD8 (Ishikawa et al., 1987; Mone et al., 1992). In (Molt4-cl8, obtained from G. Shaw), SupT1 (obtained from
J. Hoxie); HuT102, an HTLV-I-transformed and produceraddition, in vitro transformation of lymphocytes from these
primates often generates CD2/ CD25/ T cells that lack cell line (obtained from B. Hahn and G. Shaw); HT-M5V,
HT cells persistently infected with SIVsmm5 and estab-both CD4 and CD8 (Nakamura et al., 1986). Neoplastic
diseases have been reported in African monkeys infected lished in our laboratory; and Raji, a B-cell line (obtained
from S. McDougal). All continuous cell lines were main-with both SIV and STLV-I. Two cases involved sooty man-
gabeys in a captive breeding colony; one animal was tained in RPMI 1640 medium containing 10% fetal bovine
serum (FBS), glutamine, and antibiotic–antimycoticdiagnosed with CD8/ T-cell leukemia with skin lesions
and lymphadenopathy, and the other mangabey exhibited agents (RPMI-10%). Cell viabilities were determined by
trypan blue dye exclusion. Cell-associated STLV-I waschronic lymphocytosis with lymphoid interstitial pneumo-
nia and pulmonary syncytial cells (McClure et al., 1992). transmitted to normal macaque or mangabey PBMC by
treating the producer mangabey cell lines with 50 mgThe third case was an African green monkey in which
both lymphoproliferative disease and immunodeficiency, mitomycin C for 30 min, washing the cells extensively,
and then coculturing the treated cells with normal PBMC.with 5% CD4/ lymphocytes, were clearly documented
(Traina-Dorge et al., 1992). Since immunodeficiency dis- Production of STLV-I p24gag in culture supernatants was
monitored with a commercially available HTLV-I/II anti-ease has rarely been reported in African green monkeys
naturally infected with SIV, this may be a clear case of gen assay kit (Coulter, Hiahleah, FL). First-passage
stocks of the original SIVsmm9 and SIV-PBj14 isolatesenhancement of disease potential due to coinfection.
From among the original sooty mangabey SIV isolates, were generated in mitogen-stimulated human PBMC and
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were used to initiate in vitro infections of cells (Fultz et last time with 2% FBS. The nonadherent cells were incu-
bated with dialyzed Leu2a (CD8) monoclonal antibodyal., 1986, 1989).
with gentle agitation for 45 min at 47, washed twice, and
Radioimmunoprecipitation assays and antibodies then added to the precoated plates. After a 60-min incu-
bation during which the plate was swirled intermittently,Radioimmunoprecipitation (RIP) assays of viral pro-
the nonadherent cells were removed and washed, andteins expressed in various cell lines were performed after
FACS analysis was performed. The CD4/-enriched cellsmetabolic labeling of the cells with [35S]methionine and
were stimulated with concanavalin A (Con A) for 3 days,[35S]cysteine (Transblot, ICN), as described (Hu et al.,
and then parallel cultures of 107 cells (in 10 ml RPMI-1987). The sources of antibodies specific for SIVsmm
10% medium with IL-2, 10 U/ml) were mock-infected orand HTLV-I/STLV-I were, respectively, pooled serum from
inoculated with equal amounts of SIVsmm9 or SIV-PBj14.SIVsmm-infected monkeys and plasma from a person
Every 3 to 5 days, about 30% of the cell-free medium wasinfected with HTLV-I (kindly provided by G. Shaw). Be-
removed and replaced with fresh medium; a portion wascause of their close genetic homology, the anti-HTLV-I
assayed for particulate reverse transcriptase (RT) activityserum displays comparable reactivity to HTLV-I and
to monitor virus production.STLV-I (Watanabe et al., 1985, 1986; for review, see
Franchini, 1995). Polyclonal goat antiserum to purified
Syncytia assaysHTLV-I p24 Gag and rabbit monoclonal antibody to the
HTLV-I gp46 were provided by M. Robert-Guroff and G. To determine whether various combinations of in-
Franchini (National Cancer Institute). Anti-HTLV-I gp46 fected and uninfected cell lines interacted to form syncy-
monoclonal antibody 1C11 and polyclonal goat (21) anti- tia, 96-well plates were coated with poly-L-lysine at room
serum to HTLV-I env-encoded synthetic peptides were temperature for 1 hr on a rocker platform and washed
obtained from T. Palker (Duke University); HTLV-I Tax- once with PBS. Either 5 1 104 or 1 1 105 indicator cells
specific antiserum was provided by J. Sodroski (Dana in 0.1 ml RPMI-10% medium were added to appropriate
Farber Cancer Institute). Serum from an uninfected mon- wells and incubated for 45 min in a CO2 incubator, after
key was used as a normal control. which 5 1 103 or 1 1 104 virus-infected cells suspended
in 0.1 ml medium were added to each indicator cell line.
Flow cytometry The numbers of cells used for each cell–cell combination
were optimized by testing various pair-wise concentra-Cell surface antigens were detected by FACS analysis
tions of cells so that approximately 100 syncytia were(FACS-STAR, Becton-Dickinson) with FITC- or PE-labeled
formed. After 24 and 48 hr of incubation at 377 in a CO2monoclonal antibodies to human antigens that cross-
incubator, the number of syncytia was counted using anreact with the simian counterparts. The specific antigens
inverted-phase light microscope. All assays were doneand antibodies were as follows: CD2, Leu5b; CD4, Leu3a;
in triplicate wells at least twice. In experiments to testCD8, Leu2a; CD14, LeuM3; CD20, Leu16; CD25, anti-
whether syncytia formation could be inhibited, antibodiesinterleukin 2 receptor a chain (IL-2Ra); and CD56, Leu19
were incubated with cells for 45 min at room temperature(all from Becton-Dickinson). An indirect immunofluores-
before the cells were added to 5 1 104 indicator cells incence assay was used to evaluate expression of retrovi-
96-well plates. In these assays, the normal macaque,ral glycoproteins on the cell surface by FACS analysis.
polyclonal human anti-HTLV-I, macaque anti-SIVsmm,Cells were first incubated with polyclonal human or sim-
and goat 21 anti-HTLV-I Env sera were heat-inactivatedian antiserum to HTLV-I or SIV, respectively, washed,
and used at a 1:50 dilution (2 mg/well) unless otherwiseincubated with FITC-labeled goat anti-human IgG anti-
stated. The monoclonal antibody to HTLV-I gp46 was inbodies, and fixed with 1% paraformaldehyde.
ascites fluid; 2 ml of a 1:50 dilution was used in syncytia
assays.SIV infectivity of CD4-enriched PBMC in vitro
PBMC from uninfected or naturally SIVsmm-infected Proliferation assays
mangabeys were isolated from heparinized whole blood
by LSM (Organon Teknika) separation. To enrich for PBMC from macaque monkeys were used as respond-
ers in assays to evaluate the ability of various cell linesCD4/ lymphocytes, PBMC were incubated overnight at
377 in a T25 culture flask to remove adherent cells. The to induce cellular proliferation. Cell lines were treated
with 1% paraformaldehyde for 1 hr at room temperaturenonadherent cells were removed by gentle pipetting with
RPMI-10% medium, and an indirect panning method was and then washed three times with PBS; 5 1 104 cells (in
0.1 ml RPMI 1640 containing 14% human AB serum) wereused to enrich for the CD4/ lymphocytes. Briefly, 121 75-
mm polystyrene tissue culture plates treated with poly-L- added to wells in 96-well flat-bottomed plates. Equal
numbers of responder cells in 0.1 ml medium were addedlysine were incubated overnight at 47 with 75 mg goat
anti-mouse IgG in 10 ml PBS, washed, blocked with 5% to quadruplicate wells containing each stimulator cell
line, and after 3 days of incubation, 1 mCi [3H]thymidinebovine serum albumin, and washed several times, the
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was added to each well. The plates were incubated over-
night, cells were harvested, and the amount of radioactiv-
ity incorporated into DNA was counted in a beta counter.
Control wells contained either stimulator or responder
cells to which medium only or phytohemagglutinin (0.1
ml of 1:500 dilution) was added. Stimulation indices for
the responder cells were defined as counts per minute
incorporated in the presence of stimulator divided by
counts per minute incorporated in medium alone.
PCR and sequence analysis
Using conserved sequences in the env-pX region of
prototypic HTLV-I(ATK) and STLV-I(PtM3) strains (Wata-
nabe et al., 1985), primers were designed for PCR amplifi-
cation of the entire env gene; proviral DNA was extracted
FIG. 1. Replication of SIV-PBj14 and SIVsmm9 in CD4/-enriched
from the continuous cell lines 11F-FEd-M9 and FAi-FEd- PBMC from an uninfected (dashed lines) or naturally SIVsmm-infected
P14 with phenol–chloroform and ethanol precipitation (solid lines) mangabey. CD4/-enriched cells were stimulated with Con
A for 3 days and then were infected with equivalent amounts (2.5 1using standard procedures. Using 40 pmol of each
105 cpm of RT activity) of first-passage stocks of SIV-PBj14 (l) orprimer, ENV A, 5*-GGCCCCGCCGATCCCAAAGAAAA-
SIVsmm9 (j) or were not infected with exogenous SIV (m).AGA-3* [nucleotides (nt) 5145–5170, relative to the HTLV-
I(ATK) genome] and ENV B, 5*-GAGGTTAACTATTGGCA-
GGGGAGGCTG-3* (nt 6709–6683), a 1.5-kb fragment amounts of virus were produced in these and the
was amplified. Reaction conditions were denaturation at SIVsmm9-superinfected cultures. However, when virus
967 for 2 min and then 947 for 1 min, 607 for 45 sec, production by PBMC from an uninfected mangabey was
and 727 for 3 min for 30 cycles. The DNA amplification compared to that by FEd’s cells, 2- to 5-fold higher levels
products were purified and ligated into the TA cloning of both SIV-PBj14 and SIVsmm9 were detected in cells
vector (TA cloning kit, Invitrogen), which was then used from the uninfected animal (data not shown). To deter-
to transform JM109 cells. Purified plasmid DNA was di- mine whether these results might be attributed to CD8/
gested with the appropriate restriction enzymes, and the lymphocyte suppression of virus replication, the experi-
nucleotide sequence was obtained by the dideoxy chain- ment was repeated using CD4/-enriched lymphocytes
termination method (Sequenase version 2 kit, U. S. Bio- from FEd and an uninfected mangabey (FJi). Even with
chemicals). The entire STLV-I(sm) env gene from three greater than 90% of the CD8/ cells removed, the amount
different cell lines was sequenced independently by two of virus produced in the superinfected FEd cultures was
individuals. This sequence was submitted to the Gen- less than that in parallel cultures established with cells
Bank database and assigned Accession No. U94516. from the uninfected mangabey (Fig. 1). Of interest, by
The oligonucleotide primers and conditions for amplifi- about 6 weeks after initiation, virus production still per-
cation of an approximately 500-bp fragment spanning the sisted in the FEd cultures but had diminished to undetect-
NF-kB site in the U3 enhancer region of the SIVsmm LTR able levels in cultures from uninfected mangabeys.
were described previously (Tao and Fultz, 1995). The FEd culture to which no exogenous virus was
added was discarded on Day 58 after initiation because
RESULTS of extensive cell death (cell viability 1.4%). At this time
the two FEd cultures inoculated with SIVsmm9 or SIV-Establishment of mangabey cell lines
PBj14 had cell viabilities of 47 and 11%, respectively, with
RT activities of 1 1 105 and 9.3 1 105 cpm/ml. DuringIn multiple experiments to assess the ability of SIV-
PBj14 and its parental strain, SIVsmm9, to replicate in the next 18 months these cultures were maintained con-
tinuously, subject only to changes of medium (RPMI-10%cells from uninfected and SIV-infected mangabeys,
PBMC from FEd, the naturally infected mangabey from containing IL-2) every 4 to 5 days, with periodic RT
assays and determinations of cell viability. No freshwhich SIVsmm9 was originally isolated, were used (Fultz
et al., 1986). Infection of FEd’s mitogen-activated PBMC PBMC were added at any time. The cultures were also
assessed by electron microscopy (EM) at 3 months. Typi-with SIV-PBj14 consistently resulted in 5- to 10-fold
higher levels of virus (extracellular RT activity) compared cal lentivirus particles were seen in the culture infected
with SIV-PBj14 (designated FEd-P14), but, surprisingly,to infection with SIVsmm9 or when no exogenous virus
was added. Basal levels of virus produced by PBMC from only C-type retroviral particles were observed in the cul-
ture exposed to SIVsmm9 (FEd-M9) (data not shown).FEd represented SIV proviral DNA expression that was
induced in vitro by mitogen stimulation; equivalent Retrospective analysis of serum samples from FEd re-
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vealed that this mangabey had seroconverted to STLV-I cells (see below). Because no SIV proviral DNA was
during the 4 years between the original isolation of detected (by PCR) in the FEd-M9 cells, nor SIV p27gag in
SIVsmm9 and the time PBMC were obtained for the su- culture media, they appeared to be infected only with
perinfection experiments. Until approximately 400 days, STLV-I(sm).
RT activity in both cultures fluctuated between 7.5 1 103 In contrast, antigen-capture assays showed that the
and 1.3 1 105 cpm/ml, and the percentage viabilities FEd-P14 culture medium contained both SIV and STLV-
ranged from 15 to 55%, with that of the FEd-P14 cells I(sm) Gag antigens, with four- to fivefold more SIV Gag
typically lower. However, after this time, the RT activity (Table 1). This result was consistent with the EM obser-
in the FEd-P14 culture increased and was consistently vation that most virions appeared morphologically to be
1 1 106 to 2 1 106 cpm/ml, whereas that in the FEd-M9 lentiviruses. Surprisingly, indirect immunofluorescence
culture declined to baseline levels. Because the FEd-P14 FACS analysis with polyclonal antisera specific for the
cells proliferated to a greater extent than the FEd-M9 two retroviruses showed that the major envelope protein
cells, the FEd-P14 culture was expanded so that several on the Fed-P14 cell surface was the STLV-I(sm) glycopro-
flasks were maintained in parallel; all of these cultures tein (Fig. 3). Because the FEd-P14 cells had undetectable
retained the same characteristic properties. CD4 and expressed a very low level of SIV Env on their
surface, it was possible that these two proteins were
Characterization of mangabey cell lines being made, but formed intracellular complexes.
To test this possibility, FEd-P14 cell lysates were pre-
After 18 months of continuous propagation, the FEd- pared and used in RIP assays; immunoprecipitation with
P14 cultures continued to have 1 1 106 to 2 1 106 cpm SIV-specific serum revealed large amounts of a high-
of RT activity/ml, and large numbers of extracellular len- molecular-weight protein (Fig. 4). The size of this protein
tivirus-like retrovirus particles and an occasional C-type was consistent with that of the SIV-PBj14 external portion
particle were seen by EM (Fig. 2A). However, the internal of Env, but attempts to coimmunoprecipitate CD4 with
core structures in many of the lentivirus-like virions SIV-PBj14 Env were not successful. Some SIV gp120 was
looked abnormal. Attempts to transmit SIV infection to detected in culture supernatants from which virions had
normal macaque, mangabey, or human PBMC with cell-
been removed by ultracentrifugation. Using these same
free FEd-P14 culture supernatants were not successful.
lysates and either monoclonal antibodies or polyclonal
The FEd-M9 culture continued to have no detectable RT
antisera to the HTLV-I glycoprotein, it was not possible
activity, but small numbers of extracellular C-type retrovi-
to identify consistently STLV-I(sm) Env, probably because
rus particles were present (Fig. 2C). Examination of the
it has fewer cysteines and methionines and does notcultures by light microscopy revealed that the FEd-P14
incorporate as much of these radiolabeled amino acidscells were primarily single cells growing in clusters with
as SIV Env. This possibility was confirmed by RIP assaylimited numbers of small syncytia (Fig. 2B), whereas most
using [3H]leucine-labeled cell lysates, which revealedof the FEd-M9 cells were multinucleated giant cells with
somewhat higher levels of the STLV-I(sm) gp62 precursorballoon-like morphology, probably resulting from syncytia
(not shown). These results, therefore, indicated that,formation between the STLV-I(sm) glycoprotein and its
while both glycoproteins were detected intracellularly,receptor on other cells in the culture (Fig. 2D).
the predominant glycoprotein on the cell surface wasBy FACS analysis, the surface phenotype of the FEd-
STLV-I(sm) Env.P14 cells was CD2/ CD40 CD80 CD200 CD25/ or that
In agreement with the antigen-capture results for theof an activated T cell. Comparison of parallel cultures of
FEd-P14 culture medium, comparable amounts of theFEd-P14 cells maintained in medium with or without IL-
Gag capsid proteins from both retroviruses were de-2 showed that these cells no longer required IL-2 for
tected intracellularly. A protein band that migrated some-growth; cell numbers and viabilities and RT activity in
what slower than the HTLV-I 40-kDa tax-encoded proteinculture supernatants were indistinguishable over a 2-
was immunoprecipitated from FEd-P14 lysates by bothmonth period (data not shown). Although the FEd-M9
antisera, but its identity was not established. This proteincells had been in continuous culture as long as the FEd-
was not immunoprecipitated with the HTLV-I gp46 Env-P14 cells (550 days), the viability (which began to de-
specific antibodies or with the anti-Tax antibodies usedcline after 400 days) and total number of the FEd-M9
to identify Tax in the HuT102 cell lysate (not shown).cells continued to be extremely low, which precluded
Because the protein band of about 42 kDa that was immu-determining their phenotype or using them in additional
noprecipitated with the anti-SIV serum always appearedexperiments. However, antigen-capture assays for HTLV-
diffuse, it is possible that it is the SIV-PBj14 transmem-I p24gag and SIV p27gag antigens showed consistently
brane portion (gp41) of Env. In contrast, the band immuno-high levels of p24gag, indicating that the FEd-M9 cells
precipitated with the anti-HTLV-I serum was never dif-were productively infected with a virus highly related to
fuse, suggesting that these two antisera may be recogniz-HTLV-I [which we designated STLV-I(sm)]. STLV-I(sm)
proviral DNA was also detected by PCR in the FEd-M9 ing two different proteins that comigrate on the gel.
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FIG. 2. Morphology of virions and cells by EM (A, C) and inverted-phase light microscopy (B, D) in FEd-P14 (A, B) and FEd-M9 (C, D) cultures.
Original EM print magnification, 70K; light microscopy, 401. Note virions with two core structures in A.
the Molt4-cl8, SupT1, and CD40 Raji cell lines were usedSyncytia formation
as indicator cells in syncytia assays with the following:
To elucidate the incongruity of the predominant retrovi- Molt4-cl8-PBj14, a positive control for SIV-PBj14 Env-me-
ral env glycoprotein on the surface being that of STLV- diated activity; HuT102 and 11F-FEd-M9 (see below)
I(sm) (Fig. 3), while intracellularly, the SIV-PBj14 Env was cells, for HTLV-I and STLV-I(sm) Env-mediated syncytia
prevalent (Fig. 4), the FEd-P14 cells were tested for their formation, respectively; HT-M5V cells, a prototypic, unre-
ability to form syncytia with various cell lines. Differential lated SIVsmm with an Env that does not form syncytia
syncytia formation by FEd-P14 and control cells would with SupT1 cells; and primary macaque PBMC infected
indicate which retroviral Env glycoprotein(s) was being with either SIV-PBj14 or SIVsmm9. The FEd-P14 cells and
expressed on the cell surface and mediating fusion. One all other SIV-infected cells formed syncytia with the CD4/
property of SIV-PBj14 not shared by its parent virus, indicator cell line Molt4-cl8; however, only those cells
SIVsmm9, is the ability to form syncytia with SupT1 cells infected with SIV-PBj14 formed syncytia with SupT1 cells
(Fultz et al., 1989); however, both SIV strains form syncy- (Table 2). That the FEd-P14 cells were included in this
tia with Molt4-cl8 cells. Since the FEd-M9 cells did not group suggested that some SIV-PBj14 Env might be ex-
appear to express or harbor a SIV provirus, we assumed pressed on the cell surface, even though the major ret-
the SIV env antigens in the FEd-P14 cells were being roviral surface protein was STLV-I(sm) Env.
Surprisingly, the FEd-P14 cells, but no other cell line,produced from the SIV-PBj14 superinfecting virus. Thus,
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TABLE 1
Summary of Antigenic Characterizaton of FEd-P14 Cells
Viral protein
Antigen assayed SIVsmm STLV-I(sm)
Extracellular Gag proteina
Medium at 1:10 dilution 3869 924
Medium at 1:100 dilution 1757 268
Cell surface Env b
Mean channel fluorescence
(control IgG, 26.9) 35 102
% cells gated (control IgG, 7.8) 18 98
Intracellular (RIP assay)c
Env protein /// {d
Gag protein // //
a Concentrations (pg/ml) of SIV p27 and STLV-I(sm) p24 Gag antigens
in cell-free culture supernatants (diluted 1:10 or 1:100) were measured
with commercial antigen-capture kits for SIV and HTLV-I, respectively,
according to the manufacturer’s instructions (Coulter).
b Indirect immunofluorescence FACS analysis of surface expression
of viral glycoproteins. Control values reflect results with cells incubated
only with secondary antibodies. See Fig. 3.
c The number of plus signs indicates the relative intensities of protein
bands in multiple experiments. See Fig. 4.
d The Env gp62 and gp46 were not definitively identified in all experi-
ments. FIG. 4. Intracellular expression of SIVsmm and STLV-I(sm) proteins in
FEd-P14 cells. Radiolabeled cell lysates were immunoprecipitated with
normal macaque serum or polyclonal antiserum to SIVsmm or HTLV-I,
including Molt4-cl8 infected with SIV-PBj14 and the as indicated. Control cells were HT-M5V, persistently infected with
SIVsmm, and HuT102 cells, persistently infected with HTLV-I. HTLV-IHuT102 cells, formed syncytia with Raji cells. Since syn-
p40tax and p54gag and SIV p55gag proteins were identified in other experi-cytia formation generally occurs between a retroviral gly-
ments using monoclonal antibodies to these proteins (not shown).coprotein expressed on one cell with the receptor for
that virus on the second cell, these results suggested
that the two retroviral glycoproteins produced in the FEd- HTLV-I/STLV-I and a rabbit monoclonal antibody to HTLV-
I gp46 were used in blocking experiments. Only the poly-P14 cells might be interacting in an unusual manner. To
try to resolve this conundrum, several experiments were clonal anti-HTLV-I serum completely blocked syncytia
formation between FEd-P14 cells and the two T-cell lines,done. Multiple polyclonal antisera recognizing SIV or
FIG. 3. Surface expression of SIV-PBj14 (A) and STLV-I(sm) (B) Env glycoproteins on FEd-P14 cells. Indirect immunofluorescence FACS analysis
was performed after gating on live cells according to forward- and side-scatter characteristics. Control cells were incubated only with the secondary
FITC-labeled goat anti-human IgG antibodies (solid lines).
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TABLE 2
Syncytia Formation with SIV- and STLV-I-Infected Cells
Indicator cells
Test cells Molt4-cl8 SupT1 Raji
FEd-P14 ////a / ///
Molt4-cl8-PBj14 //// // 0
HT-SIV-M5V /// 0 0
11F-FEd-M9 0 {b 0
HuT102 /// 0 0
PBMC-PBj14 /// // ND
FIG. 6. Syncytia formation between FEd-P14 cells or SIV-PBj14-in-PBMC-SIVsmm9 /// 0 ND
fected Molt4-cl8 (Molt4-cl8-P14) cells and cell lines infected with
SIVsmm (HT-M5V), HTLV-I (HuT102), or HIV-1 (HuT78-BC). Results ofa Number of plus signs indicates the relative number and size of
a representative experiment are shown.syncytia.
b Extensive clumping with a few small syncytia.
It is known that cells infected with a retrovirus gener-
ally cannot be superinfected by a second virus from theconsistent with the FACScan result that the STLV-I(sm)
same family because of down-regulation of the receptor.Env was expressed on the surface of the dually infected
Superinfection interference among HIV-1 strains and be-cells (Fig. 5). The mAb to gp46 was effective only at
tween STLV-I and HTLV-I has been demonstrated (Hartblocking fusion with the SupT1 cells, indicating that epi-
and Cloyd, 1990; Sommerfeldt and Weiss, 1990). Sincetopes other than the one recognized by this mAb were
the SIV/HIV and STLV/HTLV families use different recep-participating in syncytia formation. If fusion between Fed-
tors, failure of the FEd-P14 cells to form syncytia withP14 and SupT1 cells was mediated only by SIV-PBj14
cells infected with one of these two viruses would implyEnv, the ability of the HTLV-I antibodies to block these
that the major FEd-P14 Env protein was of the samesyncytia could be explained by steric hindrance due to
family as that expressed by the infected indicator cells.the relative proportions of the two glycoproteins on the
Comparison of syncytia formation between the FEd-P14Fed-P14 cells, which differed greatly (Fig. 3). Because
or Molt4-cl8-PBj14 cells and the Molt4-cl8 uninfectedantisera to both SIVsmm and HTLV-I partially blocked
cells (positive control) or other infected cell lines demon-syncytia formation with Raji cells, this result provided
strated that FEd-P14 cells did not form syncytia with theevidence for the possibility of aberrant interactions be-
CD4/ HuT102 cells, whereas syncytia were detectedtween the two glycoproteins. Although simian type D
when the dually infected mangabey cells were incubatedretroviruses form syncytia with Raji cells, there was no
with HuT78 cells infected with the HIV-1 strain BC (Fig.evidence of type D infection in the mangabey cell lines.
6). In contrast, the reverse was true of the Molt4-cl8-These retroviruses can be distinguished from lentivi-
PBj14 cells. These results are consistent with the STLV-ruses by the presence of intracytoplasmic nucleocap-
I(sm) glycoprotein being on the cell surface and withsids, none of which were seen in the electron micro-
viral interference (loss of the surface receptor) blockinggraphs.
FIG. 5. Inhibition of syncytia formation between FEd-P14 cells and FIG. 7. Induction of proliferation of normal pig-tailed macaque PBMC
or CD4/-enriched cells by paraformaldehyde-fixed STLV-I(sm)- orcontinuous cell lines by polyclonal antiserum or a monoclonal antibody
to HTLV-I gp46. Values shown are the mean number of syncytia in HTLV-I-infected T-cell lines. Results of a representative experiment in
which cells from three different macaques were used as responderstriplicate wells of 96-well plates. Results of a representative experiment
are shown. are shown.
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FIG. 8. Nucleotide sequences of a portion of the U3 LTR region of five TA clones obtained from FEd-P14 cells after PCR amplification of proviral
DNA. The 22-bp region and its duplication (shaded) containing the NF-kB-binding site (boxed) are shown. The three unshaded boxed sequences
are binding sites for the Sp1 transcription factor. The reference SIVsmm sequence identified as BCL3 is that of biological clone 3 derived by limiting
dilution of SIV-PBj14 (Fultz et al., 1989; Dewhurst et al., 1990).
syncytia formation between FEd-P14 and HuT102 cells. resting human T lymphocytes (Gazzola and DucDodon,
1987; Wucherpfennig et al., 1992; Kimata et al., 1993), itThat neither of the SIV-PBj14-infected cell lines formed
syncytia with HT-M5V suggests that these HT cells do was of interest to determine whether the FEd-P14 cells
exhibited this property. Because SIV-PBj14 can inducenot express the receptor for STLV-I(sm).
Finally, if any syncytia formation between the FEd-P14 proliferation of resting macaque lymphocytes, Molt4-cl8
cells persistently infected with SIV-PBj14 were includedcells and the T-cell lines was mediated by SIV-PBj14 Env,
then it should be dependent on CD4 binding. However, in the assay. Positive and negative control stimulator
cells were HuT102 and uninfected Molt4-cl8 cells, re-while syncytia formation between uninfected Molt4-cl8
cells and Molt4-cl8-PBj14 was blocked completely by spectively. In all experiments, only the fixed FEd-P14 and
HuT102 cells induced proliferation of PBMC from normalpreincubation of the infected cells with 25 mg of a soluble
CD4–immunoglobulin hybrid molecule, CD4H23 (Lang- macaques (Fig. 7). Furthermore, the STLV-I(sm)- and
HTLV-I-infected cells were mitogenic for CD4/-enrichedner et al., 1993), this inhibitor had no effect on FEd-P14-
mediated syncytia (data not shown). These data together macaque PBMC, which is consistent with results of Duc-
Dodon et al. (1989) showing that this mitogenic effectindicate that, although large amounts of the SIV glycopro-
tein are synthesized in the FEd-P14 cells, the glycopro- does not require accessory cells.
tein is not expressed on the surface of the cells in any
appreciable amount. Identification of SIVsmmPBj14 proviral DNA in FEd-
P14 cellsInduction of proliferation
Because irradiated or fixed cells infected with HTLV-I SIV-PBj14 can be distinguished from the parental
exert a mitogenic effect on and induce proliferation of SIVsmm9 with which mangabey FEd was naturally in-
fected by a unique 22-bp duplication in the U3 LTR region
of the SIV-PBj14 genome (Dewhurst et al., 1990). Thus,TABLE 3
to determine whether the SIV proteins in the FEd-P14
Changes in Surface Antigen of Normal Macaque (11F) and Manga-
cells (detected by RIP assay) were being expressed frombey (FAi) PBMC after Coculture with STLV-I(sm)-Transformed Lym-
SIV-PBj14 or SIVsmm9 proviral DNA, PCR amplificationphocytes (FEd-M9)
of high-molecular-weight DNA from FEd-P14 cells was
11F-FEd-M9 FAi-FEd-M9 performed. Nucleotide sequence data of 10 PCR-derived
Surface clones showed that all had the 22-bp duplication, con-
antigen 2 months 7 months 2 months 7 months
firming that the FEd-P14 cells were persistently infected
with SIV-PBj14 (Fig. 8).CD2 38.8 35.2 86.3 98.9
CD4 22.3 0.5 17.6 3.1
CD8 22.4 3.9 13.9 1.4 Rescue of STLV-I(sm)
CD20 3.6 2.8 3.1 1.7
CD25 18.1 79.1 58.8 97.7 Because the FEd-M9 cells, which contain only STLV-
CD56 ND 39.1 ND 1.8 I(sm), eventually appeared to be terminal, aliquots were
cocultivated with PBMC from a normal pig-tailed ma-Note. Values are percentages of gated live cells that expressed the
caque (animal 11F) and a normal mangabey (FAi). Earlyindicated surface antigen, as determined by FACS analysis, at the
indicated times after establishing the cocultures with FEd-M9 cells. after cocultivation, the surface phenotype of the cells in
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FIG. 9. STLV-I and HTLV-I full-length env gene nucleotide sequence alignment. The STLV-I(sm) sequence was obtained from the 11F-FEd-P14
cell line and is aligned with representative HTLV-I strains (ATK, HS-35, EL, SP, MSHR1) and STLV-I (PtM3).
both cocultures was heterogeneous, reflecting the fact duced only STLV-I(sm) antigens, as determined by RIP
and antigen-capture assays (data not shown). After morethat they were initiated with PBMC and that the FEd-M9
cells were not the predominant cells in culture (Table than 200 days in continuous culture in IL-2-supple-
mented medium, the surface phenotype of the FAi-FEd-3). From these cocultivations, continuous cell lines from
both species were derived. Both of these cell lines, des- M9, but not the 11F-FEd-M9, cells was homogeneous
(Table 3). Both cell lines continued to produce STLV-ignated 11F-FEd-M9 and FAi-FEd-M9, respectively, pro-
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FIG. 9 —Continued
contrast, this STLV-I(sm) gene exhibited 95.2 and 96.3%I(sm) antigens from proviruses which were amplified by
homology to HTLV-I isolates from Japan (ATK) and AfricaPCR (see below).
(EL), respectively (Fig. 9). A phylogenetic tree constructed
with full-length env sequences from representativeSequence analysis of the STLV-I(sm) env gene
HTLV/STLV-I isolates confirmed that STLV-I(sm) was
To obtain preliminary evidence about the relationship more closely related to ‘‘cosmopolitan’’ HTLV-I strains
of the mangabey STLV-I to HTLV-I and the prototype than to STLV-I(PtM3) (Fultz, 1994); this result is consistent
STLV-I strain PtM3 that was obtained from an Asian pig- with published data (Koralnik et al., 1994; Saksena et al.,
tailed macaque, the env gene was PCR amplified from 1994). As independent confirmation for the authenticity
proviral DNA in 11F-FEd-M9 cells, which harbored only of the STLV-I(sm) env gene sequence, several months
STLV-I(sm). Nucleotide sequence analysis of the full- later this gene was PCR amplified and sequenced from
length env gene showed that STLV-I(sm) had only 88.4% proviral DNA in both the FAi-FEd-M9 and the dually in-
fected FEd-P14 cells. The maximum difference betweennucleotide sequence homology with STLV-I(PtM3). In
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FIG. 9 —Continued
any two of the three proviral env genes in these three dotypes formed between these two viruses might extend
the types of cells that each infects. This phenomenoncell lines was only four bases. Since the FEd-P14 and
the other two cell lines had been maintained indepen- has been demonstrated in vitro, but not in vivo (Lusso et
al., 1990; Spector et al., 1990; Landau et al., 1991). Thus,dently for more than 2 years, these results not only veri-
fied the uniqueness of the STLV-I(sm) isolate, but also interactions between these two viruses can occur at two
levels: within a cell and within a host where diseaseshowed that its genome was stable. This conclusion
agrees with those of Nerurkar et al. (1993), who demon- manifestations or progression might be altered.
We generated continuous simian cell lines that werestrated that HTLV-I proviruses in long-term cultures of
cell lines established directly from PBMC were stable infected either with a new STLV-I isolate from sooty man-
gabeys, STLV-I(sm), or with both STLV-I(sm) and SIV-and had not accumulated mutations when later com-
pared to proviral DNA in fresh PBMC from the same PBj14. CD4/-enriched PBMC from mangabey FEd, which
was naturally infected with both SIVsmm9 and STLV-individual. The entire nucleotide sequence and a com-
prehensive genetic analysis of STLV-I(sm) will be pub- I(sm), were superinfected in vitro with SIVsmm9 and SIV-
PBj14 and then maintained past the lytic phase of infec-lished elsewhere.
tion. Neither of the cell lines harbored the original virus,
SIVsmm9; however, the FEd-P14 cell line was persis-DISCUSSION
tently infected with both STLV-I(sm) and SIV-PBj14, while
There are two retrovirus families known to be patho- FEd-M9 cells were infected only with STLV-I(sm). These
genic for humans, and members of both families, HIV results were demonstrated by EM, antigen-capture
and HTLV, can establish infections and coexist in the assays for the respective Gag proteins in culture fluid,
same individual (Getchell et al., 1987; Baurmann et al., RIP assays, and PCR amplification of proviral sequences
1988; Ehrlich et al., 1989; Calabro et al., 1993). Although of both viruses. Both cell lines also transmitted STLV-
these two viruses cause very different diseases, both I(sm) to uninfected macaque and mangabey PBMC, but
infect lymphoid cells and, therefore, have the potential curiously, despite very high levels of RT activity in the
to infect the same cell. In tissue culture experiments, culture supernatant of the FEd-P14 cells, attempts to in-
one outcome of coinfection is the production of virus fect PBMC with cell-free virus and to recover SIV-PBj14
pseudotypes in which the genome of one retrovirus may were unsuccessful. This failure could be related to the
be packaged in virions that have the glycoproteins of the abnormal morphology of virions observed by EM. It is
second retrovirus on their surface. Since HIV and HTLV also possible that one or more of the SIV-PBj14 acces-
sory genes in the proviruses in the FEd-P14 cells arehave different receptors and cellular tropisms, pseu-
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defective; this possibility can be assessed with additional to optimize conditions early after dual infection of ani-
mals to address the question of pseudotype formationgenetic analyses. Alternatively, if the virions were primar-
ily pseudotypes with SIV-PBj14 cores and STLV-I(sm) gly- in vivo. Such a controlled study is now in progress.
coproteins, then transmission of cell-free virus might be
difficult. Delamarre et al. (1997) recently showed that cell- ACKNOWLEDGMENTS
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